Oral isotretinoin and pregnancy prevention programmes

British Journal of Dermatology

Volumn 166, Issue 2, 2012, Pages 466-467

  Thiboutot, D ^a   Gollnick, H ^b   Bettoli, V ^c   Dreno B ^d   Kang, S ^e   Leyden, J J ^f   Shalita, A ^g   Torres, V ^h  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY OF FERRARA   (Italy)

^d HÔTEL DIEU   (France)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g SUNY Downstate Medical Center   (United States)

^h Juarez Hospital   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

ACNE; CLINICAL EVALUATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR;

ABNORMALITIES, DRUG-INDUCED; DERMATOLOGIC AGENTS; FEMALE; GUIDELINE ADHERENCE; HUMANS; ISOTRETINOIN; PREGNANCY; TERATOGENS;

EID: 84856168767     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10686.x     Document Type: Letter

References (15)

1. Crijns HJMJ, Straus SM, Gispen-de Wied C, de Jong-van den Berg LTW,. Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review. Br J Dermatol 2011; 164: 238-44.
2. Cunliffe WJ, Gould DJ,. Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J 1979; 1: 1109-10.
3. Goulden V, McGeown CH, Cunliffe WJ,. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol 1999; 141: 297-300.
4. Collier CN, Harper JC, Cafardi JA, et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 2008; 58: 56-9.
5. Koo J,. The psychosocial impact of acne: patients' perceptions. J Am Acad Dermatol 1995; 32: S26-30.
6. Kellett SC, Gawkrodger DJ,. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999; 140: 273-82.
7. Pearl A, Arroll B, Lello J, et al. The impact of acne: a study of adolescents' attitudes, perception and knowledge. N Z Med J 1998; 111: 269-71.
8. Tallab TM,. Beliefs, perceptions and psychological impact of acne vulgaris among patients in the Assir region of Saudi Arabia. West Afr J Med 2004; 23: 85-7.
9. Tan JK, Balagurusamy M, Fung K, et al. Effect of quality of life impact and clinical severity on adherence to topical acne treatment. J Cutan Med Surg 2009; 13: 204-8.
10. Tan JK, Li Y, Fung K, et al. Divergence of demographic factors associated with clinical severity compared with quality of life impact in acne. J Cutan Med Surg 2008; 12: 235-42.
11. Hassan J, Grogan S, Clark-Carter D, et al. The individual health burden of acne: appearance-related distress in male and female adolescents and adults with back, chest and facial acne. J Health Psychol 2009; 14: 1105-18.
12. Schaefer C,. Drug safety in pregnancy: utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information Services. Congenit Anom (Kyoto) 2011; 51: 6-11.
13. Mendelsohn AB, Governale L, Trontell A, et al. Changes in isotretinoin prescribing before and after implementation of the System to Manage Accutane Related Teratogenicity (SMART) risk management program. Pharmacoepidemiol Drug Saf 2005; 14: 615-18.
14. Shin J, Cheetham TC, Wong L, et al. The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system. J Am Acad Dermatol 2011; 65: 1117-25.
15. Maloney ME, Stone SP,. Isotretinoin and iPLEDGE: a view of results. J Am Acad Dermatol 2011; 65: 418-19.